{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T22:38:25Z","timestamp":1775255905585,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Orthop Surg Traumatol"],"DOI":"10.1007\/s00590-025-04477-0","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T04:45:15Z","timestamp":1756788315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Slimming the risks: GLP-1 receptor agonist therapy may reduce in-hospital complications and hospital readmissions rates for hip fractures compared to obese patients not on these medications"],"prefix":"10.1007","volume":"35","author":[{"given":"Amelia R.","family":"Goldstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip","family":"Leucht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirmal","family":"Tejwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Ganta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjit","family":"Konda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth A.","family":"Egol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"4477_CR1","doi-asserted-by":"crossref","unstructured":"Watanabe JH, Kwon J, Nan B, Reikes A trends in glucagon-like peptide 1 receptor agonist use, 2014\u20132022. https:\/\/www.japha.org\/article\/S1544-3191(23)00309-6\/fulltext Accessed 26 Mar 2025","DOI":"10.1016\/j.japh.2023.10.002"},{"key":"4477_CR2","doi-asserted-by":"publisher","unstructured":"Iepsen EW, Lundgren JR, Hartmann B, et al. GLP-1 receptor agonist treatment increases bone formation and prevents bone loss in weight-reduced obese women. J Clin Endocrinol Metab. 2015;100(8):2909-2917. https:\/\/doi.org\/10.1210\/jc.2015-1176","DOI":"10.1210\/jc.2015-1176"},{"issue":"6","key":"4477_CR3","doi-asserted-by":"publisher","first-page":"e2416775","DOI":"10.1001\/jamanetworkopen.2024.16775","volume":"7","author":"SBK Jensen","year":"2024","unstructured":"Jensen SBK, S\u00f8rensen V, Sandsdal RM et al (2024) Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment: a secondary analysis of a randomized clinical trial. JAMA Netw Open 7(6):e2416775. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.16775","journal-title":"JAMA Netw Open"},{"key":"4477_CR4","doi-asserted-by":"publisher","unstructured":"Montes Castillo MC, Mart\u00ednez Ram\u00edrez MJ, Soriano Arroyo R, et al. Glucagon-like peptide 1 and glucagon-like peptide 2 in relation to osteoporosis in non-diabetic postmenopausal women. Sci Rep. 2019;9(1):13651. https:\/\/doi.org\/10.1038\/s41598-019-50117-z","DOI":"10.1038\/s41598-019-50117-z"},{"key":"4477_CR5","doi-asserted-by":"publisher","unstructured":"Lawand JJ, Tansey PJ, Ghali A, et al. Glucagon-like peptide-1 receptor agonist use is associated with increased risk of perioperative complication and readmission following shoulder arthroplasty. J Shoulder Elbow Surg. 2025;34(5):1152-1157. https:\/\/doi.org\/10.1016\/j.jse.2024.09.012","DOI":"10.1016\/j.jse.2024.09.012"},{"issue":"3","key":"4477_CR6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.5312\/wjo.v10.i3.166","volume":"10","author":"C Downey","year":"2019","unstructured":"Downey C, Kelly M, Quinlan JF (2019) Changing trends in the mortality rate at 1-year post hip fracture: a systematic review. World J Orthop 10(3):166\u2013175. https:\/\/doi.org\/10.5312\/wjo.v10.i3.166","journal-title":"World J Orthop"},{"key":"4477_CR7","unstructured":"One-year mortality after hip fracture surgery and prognostic factors: a prospective cohort study. Sci Rep. https:\/\/www.nature.com\/articles\/s41598-019-55196-6. Accessed 26 Mar 2025"},{"issue":"9","key":"4477_CR8","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1007\/s00198-012-1964-3","volume":"23","author":"JA Kanis","year":"2012","unstructured":"Kanis JA, Od\u00e9n A, McCloskey EV, Johansson H, Wahl DA, Cooper C (2012) A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 23(9):2239\u20132256. https:\/\/doi.org\/10.1007\/s00198-012-1964-3","journal-title":"Osteoporos Int"},{"issue":"1","key":"4477_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00402-022-04338-z","volume":"143","author":"BI Boadi","year":"2022","unstructured":"Boadi BI, Belayneh R, Littlefield CP, Egol KA (2022) Patient obesity is associated with severity of proximal humerus fractures, not outcomes. Arch Orthop Trauma Surg 143(1):373\u2013379. https:\/\/doi.org\/10.1007\/s00402-022-04338-z","journal-title":"Arch Orthop Trauma Surg"},{"key":"4477_CR10","doi-asserted-by":"publisher","unstructured":"Parratte S, Pesenti S, Argenson JN. Obesity in orthopedics and trauma surgery. Orthop Traumatol Surg Res. 2014;100(1 suppl):S91-S97. https:\/\/doi.org\/10.1016\/j.otsr.2013.11.003","DOI":"10.1016\/j.otsr.2013.11.003"},{"key":"4477_CR11","doi-asserted-by":"publisher","unstructured":"Turrentine FE, Hanks JB, Schirmer BD, Stukenborg GJ. The relationship between body mass index and 30-day mortality risk, by principal surgical procedure. Arch Surg. 2012;147(3):236-242. https:\/\/doi.org\/10.1001\/archsurg.2011.310","DOI":"10.1001\/archsurg.2011.310"},{"key":"4477_CR12","doi-asserted-by":"crossref","unstructured":"Beck TJ, Petit MA, Wu G, LeBoff MS, Cauley JA, Chen Z. Does obesity really make the femur stronger? BMD, geometry, and fracture incidence in the Women\u2019s Health Initiative\u2013Observational Study. J Bone Miner Res. 2009;24(8):1369-1379. Accessed March 26, 2025.https:\/\/pubmed.ncbi.nlm.nih.gov\/19292617\/","DOI":"10.1359\/jbmr.090307"},{"key":"4477_CR13","doi-asserted-by":"crossref","unstructured":"The association of under-weight and obesity with mortality after hip arthroplasty. Age and Ageing. Oxford Academic. https:\/\/academic.oup.com\/ageing\/article\/48\/1\/94\/5126242?login=false. Accessed 26 Mar 2025","DOI":"10.1093\/ageing\/afy161"},{"issue":"1","key":"4477_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s13018-022-03131-3","volume":"17","author":"TI Yang","year":"2022","unstructured":"Yang TI, Chen YH, Chiang MH, Kuo YJ, Chen YP (2022) Inverse relation of body weight with short-term and long-term mortality following hip fracture surgery: a meta-analysis. J Orthop Surg Res 17(1):249. https:\/\/doi.org\/10.1186\/s13018-022-03131-3","journal-title":"J Orthop Surg Res"},{"issue":"6","key":"4477_CR15","doi-asserted-by":"publisher","first-page":"E971","DOI":"10.1152\/ajpendo.1999.277.6.E971","volume":"277","author":"V Mohamed-Ali","year":"1999","unstructured":"Mohamed-Ali V, Goodrick S, Bulmer K, Holly JMP, Yudkin JS, Coppack SW (1999) Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Phys-Endocrinol Metab 277(6):E971\u2013E975. https:\/\/doi.org\/10.1152\/ajpendo.1999.277.6.E971","journal-title":"Am J Phys-Endocrinol Metab"},{"key":"4477_CR16","doi-asserted-by":"publisher","unstructured":"Hedstr\u00f6m M, Ljungqvist O, Cederholm T. Metabolism and catabolism in hip fracture patients: nutritional and anabolic intervention\u2014a review. Acta Orthop. 2006;77(5):741-747. 6https:\/\/doi.org\/10.1080\/1745367061001292","DOI":"10.1080\/1745367061001292"},{"issue":"7","key":"4477_CR17","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1007\/s11999-016-5222-4","volume":"475","author":"J George","year":"2017","unstructured":"George J, Klika AK, Navale SM, Newman JM, Barsoum WK, Higuera CA (2017) Obesity epidemic: is its impact on total joint arthroplasty underestimated? An analysis of national trends. Clin Orthop Relat Res 475(7):1798\u20131806. https:\/\/doi.org\/10.1007\/s11999-016-5222-4","journal-title":"Clin Orthop Relat Res"},{"issue":"11","key":"4477_CR18","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1007\/s11999-016-5039-1","volume":"474","author":"MM Meller","year":"2016","unstructured":"Meller MM, Toossi N, Gonzalez MH, Son MS, Lau EC, Johanson N (2016) Surgical risks and costs of care are greater in patients who are super obese and undergoing THA. Clin Orthop Relat Res 474(11):2472\u20132481. https:\/\/doi.org\/10.1007\/s11999-016-5039-1","journal-title":"Clin Orthop Relat Res"},{"key":"4477_CR19","doi-asserted-by":"publisher","first-page":"638936","DOI":"10.1155\/2014\/638936","volume":"2014","author":"YN Pierpont","year":"2014","unstructured":"Pierpont YN, Dinh TP, Salas RE et al (2014) Obesity and surgical wound healing: a current review. ISRN Obes 2014:638936. https:\/\/doi.org\/10.1155\/2014\/638936","journal-title":"ISRN Obes"},{"key":"4477_CR20","doi-asserted-by":"publisher","first-page":"1148209","DOI":"10.3389\/fimmu.2023.1148209","volume":"14","author":"SF Mehdi","year":"2023","unstructured":"Mehdi SF, Pusapati S, Anwar MS et al (2023) Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent. Front Immunol 14:1148209. https:\/\/doi.org\/10.3389\/fimmu.2023.1148209","journal-title":"Front Immunol"},{"key":"4477_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.882998","author":"ZK Al-Mashhadi","year":"2022","unstructured":"Al-Mashhadi ZK, Viggers R, Fuglsang-Nielsen R, Vestergaard P, Gregersen S, Starup-Linde J (2022) The risk of major osteoporotic fractures with GLP-1 receptor agonists when compared to DPP-4 inhibitors: a Danish nationwide cohort study. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2022.882998","journal-title":"Front Endocrinol"},{"key":"4477_CR22","unstructured":"Venugopal N, Meshay I, Hagedorn J Association of GLP-1 agonists on hip fractures in a real-world cohort. https:\/\/ota.org\/sites\/files\/abstracts\/2024\/AM%2092.pdf."},{"key":"4477_CR23","doi-asserted-by":"publisher","unstructured":"Heo KY, Goel RK, Woltemath A, et al. Glucagon-like peptide-1 receptor agonist use is not associated with increased complications after total hip arthroplasty in patients who have type 2 diabetes. J Arthroplasty. 2025;40(6):1413-1418.e1. https:\/\/doi.org\/10.1016\/j.arth.2024.10.099","DOI":"10.1016\/j.arth.2024.10.099"},{"key":"4477_CR24","unstructured":"Buddhiraju A, Kagabo W, Khanuja HS, Oni JK, Nikkel LE, Hegde V Decreased risk of readmission and complications with preoperative glp-1 analog use in patients undergoing primary total joint arthroplasty. https:\/\/www.arthroplastyjournal.org\/article\/S0883-5403(24)00551-5\/abstract. Accessed 26 Mar 2025"},{"key":"4477_CR25","doi-asserted-by":"publisher","unstructured":"Aschen SZ, Zhang A, O\u2019Connell GM, et al. Association of perioperative glucagon-like peptide-1 receptor agonist use and postoperative outcomes. Ann Surg. 2025;281(4):600-607. https:\/\/doi.org\/10.1097\/SLA.0000000000006614","DOI":"10.1097\/SLA.0000000000006614"}],"container-title":["European Journal of Orthopaedic Surgery & Traumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00590-025-04477-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00590-025-04477-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00590-025-04477-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T13:44:05Z","timestamp":1767015845000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00590-025-04477-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4477"],"URL":"https:\/\/doi.org\/10.1007\/s00590-025-04477-0","relation":{},"ISSN":["1432-1068"],"issn-type":[{"value":"1432-1068","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"3 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"377"}}